Clarence Takashi Sasaki, MD, FACS

Charles W. Ohse Professor of Surgery (Otolaryngology)

Clinical Interests

  • Head and Neck Neoplasms
  • Laryngeal Diseases
  • Otorhinolaryngologic Diseases
  • Otorhinolaryngologic Neoplasms
  • Pharyngeal Diseases

Patient Care

Accepts new patients? Yes
Patient Type: Adult; Adolescent; Child; Geriatric
Referrals: From patients or physicians

Patient Care Organizations

Surgery: Otolaryngology: Head & Neck Cancer Program

Cancer Center: Head & Neck Cancers Program

Yale Medicine

Office of Cooperative Research

Board Certifications

  • Otolaryngology AB of Otolaryngology (1973)

Clinical Trials

Conditions Study Title
Larynx, Lip, Oral Cavity and Pharynx, Ill-Defined Sites A Phase II Study of Pembrolizumab for Patients With Head and Neck Squamous Cell Carcinoma With Residual Disease Following Definitive Chemoradiation
Larynx, Lip, Oral Cavity and Pharynx, Thyroid A Phase III Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Lip, Oral Cavity and Pharynx Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Lip, Oral Cavity and Pharynx Window Trial 5-aza in HNSCC, T-tare
Larynx TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.
Lip, Oral Cavity and Pharynx Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Edit this profile